Robert Ferris, MD, PhD, and colleagues report that a single administration of autologous tumor-infiltrating lymphocyte cell therapy helped stabilize metastatic head and neck squamous cell carcinoma in some patients. The post Immune cell therapy for advanced head and neck cancer helps stabilize disease appeared first on UNC Lineberger.| UNC Lineberger
Dale Ramsden, PhD, was presented with the Battle Award for his research on how cells repair DNA double-strand breaks, a critical process for maintaining genome stability and preventing cancer-causing mutations. The post Ramsden receives Battle Award for groundbreaking genome stability research appeared first on UNC Lineberger.| UNC Lineberger
A University of North Carolina at Chapel Hill clinical trial found that graphic health warnings on little cigars and cigarillos significantly increase users’ intentions to quit and promote behaviors linked to tobacco cessation. These findings could provide the cigar-specific evidence the FDA previously lacked in efforts to require cigar warnings. Published in JAMA Network Open, … Read more| Department of Family Medicine
UNC Lineberger has launched a first-of-its-kind clinical trial aimed at improving outcomes in BRAF wildtype anaplastic thyroid cancer (ATC). Siddharth Sheth, DO, MPH, and Jeffrey Blumberg, MD, FACS, are leading the trial.| UNC Lineberger
Join us in September for an exciting day-and-a-half meeting featuring 16 presentations on the latest cancer research findings, as well as celebrating UNC Lineberger's 50 years of discovery. The post 48th Annual UNC Lineberger Scientific Symposium appeared first on UNC Lineberger.| UNC Lineberger
Chad Pecot, MD, and colleagues have developed a “two-in-one” molecule that targets hard-to-treat cancers by silencing two key genes — KRAS and MYC — while also delivering drugs directly to affected tumors. The post New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes appeared first on UNC Lineberger.| UNC Lineberger
Kwame Kwofie, a citizen of Ghana, found himself in uncharted territory when he faced a head and neck cancer diagnosis thousands of miles away from home.| UNC Lineberger
UNC Lineberger's J. Kaitlin Morrison, PhD, and Carrie Lee, MD, PhD, launched a study to investigate whether UNC Health can successfully conduct hybrid cancer clinical trials across the state.| UNC Lineberger
Lisa Carey, MD, ScM, FASCO, was honored by OncLive as one of its 2025 Giants of Cancer Care for her significant contributions advancing the treatment and study of breast cancer.| UNC Lineberger
UNC Lineberger celebrated emerging scientists and clinicians at its annual training awards ceremony, recognizing outstanding graduate students and postdoctoral fellows poised to advance cancer research and patient care.| UNC Lineberger
Joshua Zeidner, MD, and colleagues report that a combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia showed high rates of complete remission in an early-phase clinical trial.| UNC Lineberger
Dr. Lisa Carey talks about the importance of research, coordinated care and helping patients make informed choices.| The University of North Carolina at Chapel Hill
With help from your doctor, you can decide how to respond to your diagnosis.| UNC Health Talk
Hanks has joined the UNC Lineberger Comprehensive Cancer Center, the UNC School of Medicine and UNC Health as an associate professor of medicine.| UNC Lineberger